Amedisys Inc

Amedisys Inc(AMED)の株式分析

$100.990

+0.010 (+0.01%)終値時点

Loading chart…
高値
101.020
始値
101.020
出来高加重平均価格
100.98
出来高
1.06M
時価総額
3.04B
安値
100.930
売買代金
107.04M
EV/EBITDA(TTM)
12.17

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.

www.amedisys.com

アナリスト評価(11)

上値余地 +2.24%
中立
5 買い
6 中立
0 売り
現在: 100.99
安値
101.00
平均
103.25
高値
110.00

RBC Capital

2025-04-16

目標株価

$100

買い

Stephens & Co.

2025-03-04

目標株価

$101

中立

Stephens & Co.

2025-02-12

目標株価

$101

中立

Deutsche Bank

2024-07-31

目標株価

$101

中立

Cantor Fitzgerald

2024-07-25

目標株価

$101

中立

バリュエーション指標

Amedisys Inc(AMED)の現在の予想PERは18.61で、5年平均は21.55です。

予想PER

適正
5年平均 P/E
21.55
現在のP/E
18.61
割高
25.36
割安
17.73

予想EV/EBITDA

適正
5年平均 EV/EBITDA
14.69
現在のEV/EBITDA
12.17
割高
17.36
割安
12.02

予想PSR

適正
5年平均 P/S
1.44
現在のP/S
1.21
割高
1.78
割安
1.09

Alphio AI による AMED の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%AMED

$104.36

シナリオ価格

基

基本

基本 · 50%AMED

$83.35

シナリオ価格

弱

弱気

弱気 · 25%AMED

$78.33

シナリオ価格

AMED のよくある質問 — Alphio AI が回答

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

11 analysts cover AMED: 5 rate it Buy, 6 Hold and 0 Sell. The average price target is 103.25.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める